Discontinued — last reported Q3 '25
Common Stock
EquityJohnson & Johnson Common Stock remained flat by 0.0% to $3.12B in Q3 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $3.12B to $3.12B. Over 3 years (FY 2021 to FY 2024), Common Stock shows relatively stable performance with a 0.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2008
Last reportedQ3 2025
How to read this metric
Changes usually reflect new share issuances or the exercise of stock-based compensation, though for mature firms, this remains relatively static.
Detailed definition
The total par value of the shares issued by the corporation to its investors. This represents the legal capital of the c...
Peer comparison
Standard across all publicly traded entities; often analyzed alongside 'Additional Paid-in Capital'.
Metric ID:
common_stockHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B | $3.12B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$3.12B – $3.12B
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak16+ quarters growth
Common Stock at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's common stock?
- Johnson & Johnson (JNJ) reported common stock of $3.12B in Q3 2025.
- How has Johnson & Johnson's common stock changed year-over-year?
- Johnson & Johnson's common stock decreased by 0.0% year-over-year, from $3.12B to $3.12B.
- What is the long-term trend for Johnson & Johnson's common stock?
- Over 3 years (2021 to 2024), Johnson & Johnson's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $3.12B to $3.12B.
- What does common stock mean?
- The base value of the shares the company has issued to its owners.